Viridian Therapeutics, Inc.\DE·4

Jan 20, 3:55 PM ET

Leverone Jason A. 4

4 · Viridian Therapeutics, Inc.\DE · Filed Jan 20, 2021

Insider Transaction Report

Form 4
Period: 2021-01-18
Leverone Jason A.
CFO, Treasurer & Secretary
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-01-18+311,785311,785 total
    Exercise: $23.03Exp: 2031-01-17Common Stock (311,785 underlying)
Footnotes (1)
  • [F1]The option vests in equal monthly installments over the following 4 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Documents

2 files